StockWatch
·
Q2 FY-2027 RESULTS · FILATEX

Filatex Q2: Revenue +21% YoY, but Cost Pressure Caps Consol PAT Growth at 10%

PAT +9.82% YoY · revenue +21.22% · margins compressing · beat vs street

Q2 FY27 resultsFILATEXFILATEX INDIA LTD.-$13 Nov 2026 · 3 min read
Revenue

₹1,304.19 Cr

+21.22% YoY

PAT (consolidated)

₹52.22 Cr

+9.82% YoY

Net margin

3.98%

-0.4pp YoY

EPS

₹1.18

Filatex India's consolidated revenue rose 21.2% YoY (13.9% QoQ) to ₹1,304.19 Cr for Q2FY27, comfortably ahead of the ~₹1,120 Cr our pre-result preview had flagged as the bar to clear. But profitability lagged the topline: consolidated PAT grew just 9.8% YoY (7.6% QoQ) to ₹52.22 Cr, with standalone PAT slightly higher at ₹53.48 Cr (+12.4% YoY) — the gap is the subsidiary Ecosis, which remains pre-revenue and is still a drag at the consolidated level. Per the hard anchor on YoY: this is a volume-led print, not a margin-led one, and profit trailing revenue by this much is the real story, not the headline growth rate.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹1,304.19 Cr+13.9%+21.2%
Expenses₹1,241.85 Cr+13.9%+22%
PAT₹52.22 Cr+7.63%+9.82%
Net margin3.98%-0.2pp-0.4pp
EPS₹1.18+8.3%+10.3%

The margin bridge explains why. Standalone EBITDA margin came in at 6.98%, down 129 bps YoY from 8.27% in Q2FY26, as elevated PTA/MEG costs amid continued West Asia geopolitical tensions pressured the cost line; consolidated NPM eased to 3.98% from 4.40% a year ago. Sequentially, EBITDA margin actually ticked up 18 bps (6.80% to 6.98%) as cost pass-through improved and need-based buying eased, but QoQ NPM still slipped slightly (4.20% to 3.98%) on lower other income (₹9.86 Cr to ₹8.06 Cr, consolidated). Against our own pre-result watch item of EBITDA margin ≥7.5% (standalone), the quarter missed.

₹
68.6780.6692.66104.65116.64100.6908-1009-0109-2410-1911-1111-13Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹100.69, down 9.9% over the past month of trading.

₹ Cr
020.5241.0461.5640.66Q1 FY26rev ₹1,049 Cr47.55Q2 FY26rev ₹1,076 Cr54.96Q3 FY26rev ₹1,050 Cr40.08Q4 FY26rev ₹985 Cr48.52Q1 FY27rev ₹1,145 Cr52.22Q2 FY27rev ₹1,304 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.

What management guided (1 FY-2027 call)
₹690Cr CAPEX 50% by Sep26, balance Oct26. Ecosis ₹80-90Cr EBITDA target with 30%+ margins; 2 more plants planned (1.5M TPD each) in 2-3yr. PFI expansion adds ₹400Cr full-year revenue (₹150-200Cr FY27). Peak net debt ₹150-200Cr by year-end.

— This quarter: missed

On guidance, the quarter is mixed. The ₹235 Cr PFY brownfield expansion (~55,000 TPA) is partially commissioned with the balance now pushed to end-November 2026 (versus the prior Oct-26 indication), and the ₹300 Cr Ecosis recycling project has slipped to Q3FY27 commissioning, with a further ₹20 Cr invested via rights issue in September (cumulative ₹84.98 Cr) — so the ₹80-90 Cr Ecosis EBITDA target remains unproven and off this quarter's numbers. More notable: consolidated borrowings roughly tripled from March 2026 levels (₹127.9 Cr to ₹388.5 Cr) as capex accelerated; netted against cash and bank balances (₹140.6 Cr) that implies ~₹248 Cr net debt already at the half-year mark, at or above the top of management's guided 'peak net debt ₹150-200 Cr by year-end' — though the company's ₹220 Cr of liquid investments could offset this materially if counted as quasi-cash. Management's own framing (CMD Madhu Sudhan Bhageria) called it 'a quarter of steady execution,' citing disciplined cost management protecting profitability in a volatile raw-material environment — consistent with the margin-compression-but-contained read here rather than a stronger characterization.

  • W1

    Ecosis commissioning in Q3FY27 and progress toward management's ₹80-90 Cr EBITDA / 30%+ margin target

  • W2

    Net debt trajectory vs management's guided 'peak ₹150-200 Cr by year-end' — already ~₹248 Cr implied at H1-end with further capex due

  • W3

    EBITDA margin recovery toward the 7.5-8.2% band as the PFY expansion's balance capacity commissions by end-Nov 2026 and India-EU FTA (signing stage, effective early 2027) aids export economics

No exceptional items in current or year-ago quarter (both bases); standalone PAT (₹53.48cr) exceeds consolidated (₹52.22cr) by ₹1.26cr, reflecting pre-commissioning losses at wholly-owned subsidiary Ecosis Limited; company shifted presentation unit from Lakhs to Crore effective Q1FY27, this filing is natively in Crore.

Informational and educational content only. Not investment advice.